Medication info

Alphacoline Injection (Choline Alphoscerate)

Prescription medicationIntravenous injection
Ingredient · strength
Choline Alfoscerate›1g / 1 ampoule
Manufacturer / importer
Daiwon Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent injection solution in a colorless and transparent ampoule
Packaging
For domestic use: 4mL/ampoule X 10, For export: 4mL/ampoule X 10
Approval status
Active

MFDS item code 201405881 · Approved 2014.12.15

Summary

Main use
Improvement of symptoms of organic brain syndrome (memory impairment, etc.) and cerebrovascular deficits
Who receives it
Adults
Adult administration
Administer 1g of choline alfoscerate once daily by intramuscular or intravenous injection. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Daiwon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of organic brain syndrome (memory impairment, etc.) and cerebrovascular deficits

  • Memory impairment
  • confusion
  • decreased drive
  • decreased spontaneity
  • disorientation
  • reduced concentration
View approved original text

This medication is effective for psychotic symptoms and organic brain syndrome due to cerebrovascular deficits. It helps improve symptoms such as memory impairment, confusion, disorientation, decreased drive and spontaneity, and reduced concentration. These symptoms primarily arise from degeneration or degenerative changes in the brain, and this medication contributes to symptom relief. Results from domestic clinical trials have also been submitted, demonstrating safety and efficacy. Therefore, this medication is used to improve symptoms associated with impaired brain function.

How it is given

Adult administration

Administer 1g of choline alfoscerate once daily by intramuscular or intravenous injection. Adjust the dose appropriately according to symptoms.

Precautions

This medication is an ampoule injection, so care must be taken when cutting the container to avoid glass fragments entering. Special caution is needed when administering to children or the elderly. This medication should not be used by individuals allergic to it or its ingredients. Women who are pregnant or may become pregnant should not receive this medication. Nausea may occur with this medication, and if such symptoms arise, the dosage should be reduced. Pain may develop at the injection site, and dry mouth may also occur. Additionally, psychological symptoms such as drowsiness, insomnia, irritability, anxiety, and skin rashes may occur. This medication should be stored out of the reach of children. Avoid transferring the medication to another container, as this may affect its quality.

Side effects

  • Nausea
  • injection site pain
  • dry mouth
  • drowsiness
  • insomnia
  • irritability
  • nervousness
  • anxiety
  • hives

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering, and it is best stored at room temperature between 1 and 30 degrees Celsius. By storing it this way, the efficacy of the medication can be well maintained and degradation can be prevented.

Appearance and packaging

Appearance

A colorless and transparent injection solution in a colorless and transparent ampoule

Package unit

For domestic use: 4mL/ampoule X 10, For export: 4mL/ampoule X 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.